Stocks and Investing
Stocks and Investing
Tue, November 16, 2021
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
[ Tue, Nov 16th 2021
] - WOPRAI
Raghuram Selvaraju Maintained (SPRB) at Strong Buy with Decreased Target to $20 on, Nov 16th, 2021
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spruce Biosciences, Inc." (SPRB) at Strong Buy with Decreased Target from $30 to $20 on, Nov 16th, 2021.
Raghuram, nor any peers, have made any analyst calls on SPRB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources